# N-Acetylcysteine Protection Against Radiation Induced Cellular Damage

Study · id `cardio:ct-nct04154982` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04154982](<https://clinicaltrials.gov/study/NCT04154982>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04154982

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 181 participants.

## Technical summary

Registry record NCT04154982. Randomized; single masking; primary purpose treatment. Start 2020-09-02 (actual); primary completion 2024-12-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 181 participants (enrolled count; ClinicalTrials.gov record NCT04154982, source copy `cardio:ctgov-nct04154982-2025-08-22`, retrieved 2026-10-26)
- Started: 2020-09-02 (actual) (ClinicalTrials.gov record NCT04154982, source copy `cardio:ctgov-nct04154982-2025-08-22`, retrieved 2026-10-26)
- Primary completion: 2024-12-02 (actual) (ClinicalTrials.gov record NCT04154982, source copy `cardio:ctgov-nct04154982-2025-08-22`, retrieved 2026-10-26)
- Completion: 2024-12-02 (actual) (ClinicalTrials.gov record NCT04154982, source copy `cardio:ctgov-nct04154982-2025-08-22`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT04154982, source copy `cardio:ctgov-nct04154982-2025-08-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04154982-2025-08-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: N-Acetylcysteine Protection Against Radiation Induced Cellular Damage
- Acronym: CARAPACE
- Condition: Cardiac Arrhythmia
- Intervention (Drug): Acetyl cysteine
- Lead sponsor: Centro Cardiologico Monzino
- Lead sponsor class: OTHER
- Collaborator: Ministry of Health, Italy
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: Centro Cardiologico Monzino (`cardio:org-centro-cardiologico-monzino`)
- Registry lists this organization as a collaborator: Ministry of Health, Italy (`cardio:org-ministry-of-health-italy`)

## Provenance

Content hash: 3ce37e3fc9955cedf806c682e24199ea1a8186d5a01c66e86ea829c17c0dbfb5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
